Login / Signup

Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II-An Updated Analysis of SEER-Medicare Data.

Ya Chen Tina ShihYing XuChun-Ru ChienBumyang KimYu ShenLiang LiDaniel M Geynisman
Published in: PharmacoEconomics (2020)
The rising economic burden of RCC was most pronounced among patients with distant-stage RCC, and driven primarily by new cancer drugs.
Keyphrases
  • renal cell carcinoma
  • papillary thyroid
  • electronic health record
  • squamous cell
  • lymph node
  • big data
  • lymph node metastasis
  • squamous cell carcinoma
  • affordable care act
  • deep learning
  • artificial intelligence